Naval Satarawala Chopra is a partner in the competition law practice at Amarchand & Mangaldas (New Delhi offices). Naval focuses on contentious cases covering the entire range of competition law, including cases on abuse of dominance, cartel investigations and merger control in India. He regularly represents clients before the Competition Commission of India and the Competition Appellate Tribunal and is a frequent commentator on competition law issues in India. Prior to joining Amarchand & Mangaldas, Naval was an associate at Freshfields Bruckhaus Deringer, in London for over four years. Naval is qualified to practice in New York, England & Wales and India. He holds an LL.B. from ILS Law College, Pune, and an LL.M. from University of Michigan, Ann Arbor.
418
On 6 November 2018, the Competition Commission of India (CCI) found that four manufacturers/traders of flashlights and their trade association (the Opposite Parties) were not involved in cartelisation as, despite an information exchange, there was not enough corroborating evidence to suggest a (...)
487
In an order dated 14 June 2018, the Competition Commission of India (CCI) approved Bayer AG’s (Bayer) acquisition of Monsanto Company (Monsanto) (together, the Parties) subject to certain modifications. Shardul Amarchand Mangaldas & Co. represented Monsanto and assisted in seeking the CCI’s (...)
163
On 10 May 2017, the Supreme Court of India published its judgment dated 8 May 2017 in Excel Crop Care Ltd. v. Competition Commission of India & Anr . This judgment deals with important issues on the applicability of the Competition Act, 2002 (Competition Act) to conduct prior to its coming (...)
277
Introduction The Competition Commission of India (CCI) in the first ever decision involving leniency in a cartel case (Suo Moto Case No. 03 of 2014 – In Re : Cartelization in respect of tenders floated by Indian Railways for supply of Brushless DC Fans and other electrical items), published on (...)
77
The Indian merger control regime under the Competition Act, 2002 (Competition Act) has been in force for nearly five years. The provisions of the Competition Act are to be read together with the notifications issued, from time to time, by the Ministry of Corporate Affairs, Government of India (...)
133
The Competition Commission of India (CCI) has recently imposed a penalty of INR 5 crores (approximately USD 750,000) on GE for its failure to notify the proposed acquisition of Alstom companies within 30 days of the trigger date. The penalty imposed on GE is the highest penalty for late filing (...)
65
The Indian merger control regime under the Competition Act, 2002 has been in force for nearly five years. In addition to the statutory provisions, the Combination Regulations were introduced by the Competition Commission of India in 2011 . These Regulations contain detailed rules on (...)
86
SUMMARY In tendering to the Food Corporation of India, three manufacturers of Aluminium Phosphide Tablets were found to have quoted the same rates, to have reduced rates by the same margin in negotiations, and to have collectively abstained from bidding. The CCI fined the parties 9% of average (...)
164
The Curious Case of Compulsory Licensing in India* In a move that has alarmed the pharmaceutical industry, in March 2012 the Indian Patents Office granted its first compulsory licence, for the manufacture and sale of Bayer’s patented drug Nexavar, in Natco Pharma Limited v Bayer Corporation (...)
68 rue Amelot
885 6th Avenue #32G
